Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors.

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Ali A. Rizvi, Giatgen A. Spinas

    Risultato della ricerca: Article

    65 Citazioni (Scopus)
    Lingua originaleEnglish
    pagine (da-a)1495-1503
    Numero di pagine9
    RivistaExpert Opinion on Investigational Drugs
    Volume18
    Stato di pubblicazionePublished - 2009

    All Science Journal Classification (ASJC) codes

    • Pharmacology
    • Pharmacology (medical)

    Cita questo

    @article{70eb2f8516634ee4967df805f1d2d0be,
    title = "Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors.",
    keywords = "aterosclerosi",
    author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Rizvi, {Ali A.} and Spinas, {Giatgen A.}",
    year = "2009",
    language = "English",
    volume = "18",
    pages = "1495--1503",
    journal = "Expert Opinion on Investigational Drugs",
    issn = "1354-3784",
    publisher = "Informa Healthcare",

    }

    TY - JOUR

    T1 - Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors.

    AU - Rini, Giovam Battista

    AU - Rizzo, Manfredi

    AU - Berneis, Kaspar

    AU - Rizvi, Ali A.

    AU - Spinas, Giatgen A.

    PY - 2009

    Y1 - 2009

    KW - aterosclerosi

    UR - http://hdl.handle.net/10447/46866

    M3 - Article

    VL - 18

    SP - 1495

    EP - 1503

    JO - Expert Opinion on Investigational Drugs

    JF - Expert Opinion on Investigational Drugs

    SN - 1354-3784

    ER -